Trevi Therapeutics Statistics

Total Valuation

TRVI has a market cap or net worth of $925.50 million. The enterprise value is $722.51 million.

Market Cap	925.50M
Enterprise Value	722.51M

Important Dates

The last earnings date was Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

TRVI has 121.78 million shares outstanding. The number of shares has increased by 14.02% in one year.

Current Share Class	121.78M
Shares Outstanding	121.78M
Shares Change (YoY)	+14.02%
Shares Change (QoQ)	+10.83%
Owned by Insiders (%)	0.81%
Owned by Institutions (%)	54.72%
Float	90.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.66
P/TBV Ratio	4.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.42, with a Debt / Equity ratio of 0.00.

Current Ratio	22.42
Quick Ratio	22.15
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-25,760.50

Financial Efficiency

Return on equity (ROE) is -35.74% and return on invested capital (ROIC) is -24.14%.

Return on Equity (ROE)	-35.74%
Return on Assets (ROA)	-22.83%
Return on Invested Capital (ROIC)	-24.14%
Return on Capital Employed (ROCE)	-25.88%
Revenue Per Employee	n/a
Profits Per Employee	-$1.82M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-46,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +178.39% in the last 52 weeks. The beta is 0.59, so TRVI's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	+178.39%
50-Day Moving Average	6.66
200-Day Moving Average	5.20
Relative Strength Index (RSI)	62.67
Average Volume (20 Days)	1,770,578

Short Selling Information

The latest short interest is 10.16 million, so 8.34% of the outstanding shares have been sold short.

Short Interest	10.16M
Short Previous Month	9.95M
Short % of Shares Out	8.34%
Short % of Float	11.21%
Short Ratio (days to cover)	5.41

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-51.52M
Pretax Income	-38.78M
Net Income	-47.30M
EBITDA	-51.37M
EBIT	-51.52M
Earnings Per Share (EPS)	-$0.42

Full Income Statement

Balance Sheet

The company has $203.89 million in cash and $891,000 in debt, giving a net cash position of $202.99 million or $1.67 per share.

Cash & Cash Equivalents	203.89M
Total Debt	891,000
Net Cash	202.99M
Net Cash Per Share	$1.67
Equity (Book Value)	198.49M
Book Value Per Share	1.63
Working Capital	197.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$42.68 million and capital expenditures -$7,000, giving a free cash flow of -$42.69 million.

Operating Cash Flow	-42.68M
Capital Expenditures	-7,000
Free Cash Flow	-42.69M
FCF Per Share	-$0.35

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TRVI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.02%
Shareholder Yield	-14.02%
Earnings Yield	-5.11%
FCF Yield	-4.61%

Analyst Forecast

The average price target for TRVI is $19.50, which is 156.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.50
Price Target Difference	156.58%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2